|
|
|
Clinical Research Detail |
|
|
|
Title Of Study |
Efficacy and safety of paclitaxel nano-dispersion concentrate for injection (PICN) in subjects with metastatic breast cancer: A randomized, open label, active controlled, comparative, parallel group, and multi-centric study
|
|
|
Disease Condition |
Female subjects with age 18 to 70-years inclusive, with histologically or cytologically confirmed metastatic breast cancer in subjects who are candidate for single agent paclitaxel therapy in accordance with standard of care.
|
|
|
Phase of Trial |
Phase-2 & 3
|
Discipline |
Oncology
|
|
|
Start date of Trial |
8/1/2010
|
Closing Date of Trial |
8/1/2012
|
|
|
|